PHA-680626 is a potent inhibitor of the interaction between Aurora-A and N-Myc; it inhibits the kinase activity of AURKA and Bcr-Abl, induces N-Myc degradation, reduces phosphorylation of CrkL and histone H3, and exhibits anti-proliferative and pro-apoptotic activity against Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells.